Remegen -H (9995.HK) traded up 3.21 % during a 24 hours period ending at 06:49 AM Central Europe on Thursday 29th. One Remegen -H stock can currently be bought for about HKD 64.15 on popular exchanges. Current supply of Remegen -H stocks is 208.6 mn. Remegen -H has a current market capitalization of HKD 37.1 bn and approximately HKD 111.3 mn worth of Remegen -H was traded on exchanges in the last 24 hours. Since last month end, Remegen -H has traded -13.97 % down. Simple moving average of last 200 days is at HKD 83.91. The highest price of past 52 weeks was recorded at HKD 123.1 on 04/20/2026. 52 weeks low was at HKD 60 on 10/23/2026.

Here is how related stocks have performed in the past 24 hours:

  • China Citic Asse-h (2799.HK) traded up 0.91 % and now trades at HKD 0.55. Current market capitalisation for China Citic Asse-h is HKD 44.5 bn. Current price/earnings ratio for China Citic Asse-h is 3.48.

  • Shanghai Allist Pharmaceut (688578.SS) traded flat 0 % and now trades at CNY 81.55. Shanghai Allist Pharmaceut has a market capitalisation of CNY 37.3 bn. Shanghai Allist Pharmaceut has a current price to earnings ratio of 20.34.

  • China Greatwall (000066.SZ) traded flat 0 % and now trades at CNY 11.43. Current market capitalisation for China Greatwall is CNY 37.9 bn. China Greatwall has a current price to earnings ratio of 314.31.

  • Tal Education (TAL) traded down -1.47 % and now trades at USD 10.06. Current market capitalisation for Tal Education is USD 5.6 bn. Current price/earnings ratio for Tal Education is 7.57.

  • Shanghai Fosun Pharmaceuti-h (2196.HK) traded up 0.73 % and now trades at HKD 16.14. Shanghai Fosun Pharmaceuti-h has a market capitalisation of HKD 44.5 bn. Shanghai Fosun Pharmaceuti-h has a current price to earnings ratio of 11.25.

About Remegen -H

RemeGen Co., Ltd., a biotechnology company based in Yantai, China, specializes in developing therapeutic antibody drugs. These include antibody drug conjugates (ADC), antibody fusion proteins, monoclonal antibodies, and double antibodies. RemeGen provides solutions for autimmune diseases, tumor diseases, and ophthalmic diseases. You can find more information about their operations on their website, www.remegen.com , and they are listed on the Hong Kong Stock Exchange.